Dr. Nathan L. Scott, MD

Dr. Scott practices at UCSD Hillcrest Medical Center in San Diego, California.

Dr. Scott's NPI, 1346622586, was assigned on June 24, 2015. Dr. Scott graduated from Harvard Medical School in 2015. Dr. Scott holds California license A179340.

Dr. Scott's primary practice is UCSD Hillcrest Medical Center, at 200 W Arbor Dr, San Diego, CA 92103 in San Diego County. The practice phone is (619) 543-6222.

Dr. Scott's primary practice is UCSD Hillcrest Medical Center in San Diego, California. Dr. Scott is also affiliated with Hillcrest Medical Center. The medical group on file is UC San Diego Health. Dmand AI also links Dr. Scott to 1 more physician office, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Scott practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Scott's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Scott is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Scott's licenses on file in 3 states: California, Florida and Massachusetts.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, dry eye, glaucoma, hypertensive retinopathy, inflammation of iris and laser destruction of retinal or choroid lesions among the conditions Dr. Scott treats.

CMS data shows 1,440 Medicare services from Dr. Scott across 15 procedure codes in 2024, for 221 Medicare patients. Medicare paid $79,829 for them. Every service was in an office.

CMS counts 221 Medicare patients who saw Dr. Scott in 2024. The largest group is 65 to 74, with 104 patients. 72% of them have high cholesterol, and 63% have high blood pressure. 20% are also on Medicaid. Their average risk score is 1.37, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Scott's median patient age at 63, with 50% women.

In 2024, Dr. Scott wrote 201 Medicare Part D claims for 59 patients. 68% of them were for generic drugs. CMS names the drug for 156 of them, across 5 drugs with 11 or more claims each, at $3,310 in total drug cost. In 2023, CMS named 36 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Scott for performance year 2024, reported as part of a group. Dr. Scott accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 15 procedures of cataract surgery by Dr. Scott, more than 39% of the clinicians it reports for that procedure.

Dmand AI links 47 papers to Dr. Scott, published from 2012 to 2025. 2024 was the busiest year, with 7. The most frequent topics are Fluorescein Angiography, Tomography, Optical Coherence and Fundus Oculi. Dr. Scott has published most often in Am J Ophthalmol Case Rep. Dr. Scott's most frequent co-authors are Jayanth Srinivasan-Kasi Sridhar, MD, Harry W. Flynn, MD and John William Hinkle, MD.

CMS Open Payments shows 42 general payments to Dr. Scott from 19 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 82% of the total. Alcon Laboratories Inc paid the most, $2,060.

Dr. Scott graduated from Harvard Medical School in 2015.

Dr. Scott is in network with 15 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. HMO plans come from the most carriers, 8. Check the plan with the practice before a visit.